
==== Front
ACS Omega
ACS Omega
ao
acsodf
ACS Omega
2470-1343
American Chemical Society

10.1021/acsomega.4c08066
Retraction
Retraction of “Toxicological Screening of 4-Phenyl-3,4-dihydrobenzo[h]quinolin-2(1H)-one: A New Potential Candidate for Alzheimer’s Treatment“
Anwar Fareeha
Saleem Uzma
Rehman Atta ur
Ahmad Bashir *
Ismail Tariq
Mirza Muhammad Usman
Kee Lee Yean
Abdullah Iskandar
Ahmad Sarfraz *
06 09 2024
17 09 2024
9 37 3929639296
02 09 2024
© 2024 The Authors. Published by American Chemical Society
2024
The Authors
https://creativecommons.org/licenses/by-nc-nd/4.0/ Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
ACS Omega2021, 6 (16), 10897−10909, DOI: 10.1021/acsomega.1c00654Universiti Malaya 10.13039/501100004386 IIRG003A-2019 document-id-old-9ao4c08066
document-id-new-14ao4c08066
ccc-price
==== Body
pmcThe authors retract this article (DOI: 10.1021/acsomega.1c00654) due to the image duplication. The authors were simultaneously working on multiple articles and inadvertently interchanged images between different studies. Therefore, images of histopathology slides in Figure 9 (acute oral toxicity and teratogenicity) of DOI: 10.1021/acsomega.1c00654 are identical to those in articles published afterward: Figure 8 of DOI: 10.3389/fphar.2021.607026, Figure 2 of DOI: 10.3389/fphar.2023.1111915, and Figure 2 of DOI: 10.3389/fphar.2023.1119360. The authors have agreed that such actions potentially provide misleading conclusions and analysis of experiments, raising significant doubts on the main findings of the work. As such, the article is being retracted.

The original Article was published on April 16, 2021, and was retracted on September 6, 2024.
